Top 10 ASX Dividend Stocks for Nov 2026 Download Free Report

Healthcare

How Much is ResMed (ASX:RMD) Worth by Market Capitalisation?

ResMed Inc (ASX:RMD) traded lower during the latest session, with the stock declining 4.861% to AUD 28.570. The fall followed the previous closing price of AUD 30.030.

Sonal Goyal | 13 July 2026

Is Mesoblast (ASX:MSB) Trading Above its 52-Week Low?

Mesoblast Limited (ASX:MSB) traded higher during the latest session, with the stock rising 4.910% to AUD 2.350. The gain came after the stock closed at AUD 2.240 in the previous session.

Sonal Goyal | 13 July 2026

Cogstate (ASX:CGS): What Stands Out in Company's Latest Financial Performance

The announcement centred on a 4Q26 and FY26 business update highlighting record net sales contracts and growing contracted future revenue. Key points disclosed include:

Sonal Goyal | 11 July 2026

Ramsay Health Care (ASX:RHC) Pulls Back as Hospital Stocks Face Investor Scrutiny

Ramsay Health Care (ASX:RHC) is a name investors frequently monitor, so any period of share-price weakness tends to draw commentary. The company recently appeared among ASX stocks that experienced downward pressure during a session in which healthcare and hospital operators faced renewed scrutiny. Given …

Aditi Sarkar | 10 July 2026

Sigma Healthcare (ASX:SIG) Pulls Back as Investors Reassess Recent Momentum

Sigma Healthcare (ASX:SIG) drew market attention after its share price pulled back following an extended period of strong momentum. When a company that has re-rated substantially, in Sigma’s case in the wake of a landmark merger, experiences a decline, market participants often ask whether …

Aditi Sarkar | 10 July 2026

SomnoMed (ASX:SOM) Falls as Medical Device Stocks Face a Volatile Session

SomnoMed (ASX:SOM) attracted attention after its share price appeared to soften during a session in which a range of medical-device and small-cap names came under pressure. When a company that has recently reported strong operational progress sees its shares pull back, market participants often …

Aditi Sarkar | 10 July 2026

Telix Pharmaceuticals (ASX:TLX) Pulls Back: Is the Healthcare Growth Trade Cooling?

Telix Pharmaceuticals (ASX:TLX) attracted attention as its share price pulled back, raising the question in some quarters of whether the enthusiasm that has surrounded high-growth healthcare stocks may be moderating. Telix has been one of the more closely followed names in Australian healthcare, and …

Aditi Sarkar | 10 July 2026

Vitrafy Life Sciences (ASX:VFY) Drops as Med-Tech Volatility Returns

Vitrafy Life Sciences was among the ASX names drawing attention on 10 July 2026 during a session in which med-tech volatility appeared to return. Smaller, earlier-stage medical-technology companies can be especially sensitive to shifts in market mood, because much of their perceived value rests …

Aditi Sarkar | 10 July 2026

Pro Medicus (ASX:PME) Pulls Back: Is the ASX Healthcare Giant Taking a Pause?

HighlightsPro Medicus (ASX:PME) came into focus after its share price eased, with the pullback potentially reflecting a pause in one of the ASX’s strongest-performing large-cap growth stories rather than any confirmed change in the business.The company is a global leader in cloud-based medical imaging …

Aditi Sarkar | 10 July 2026

Polynovo (ASX:PNV) Drops as Healthcare Growth Stocks Face a Market Pause

Polynovo (ASX:PNV) attracted attention during a session in which a number of ASX healthcare and growth-oriented stocks appeared to lose ground together. When names across a theme move in the same direction on the same day, it can be difficult to separate a company-specific …

Aditi Sarkar | 10 July 2026
Support

Hi! How can we help you today?

Loading…